Close Menu
    Facebook X (Twitter) Instagram
    SciTechDaily
    • Biology
    • Chemistry
    • Earth
    • Health
    • Physics
    • Science
    • Space
    • Technology
    Facebook X (Twitter) Pinterest YouTube RSS
    SciTechDaily
    Home»Health»Scientists Discover a Powerful New Way To Kill Prostate Cancer Cells
    Health

    Scientists Discover a Powerful New Way To Kill Prostate Cancer Cells

    By University of MichiganNovember 17, 2026No Comments4 Mins Read
    Facebook Twitter Pinterest Telegram LinkedIn WhatsApp Email Reddit
    Share
    Facebook Twitter LinkedIn Pinterest Telegram Email Reddit
    Illustration of DALTAC 1 Linking AR and p300
    The gears represent the androgen receptor (AR) and p300, which are linked together in a non-native interaction by the monkey wrench, representing DALTAC-1. This leads to inhibition of oncogenic AR transcription and suppression of prostate tumor growth. Credit: Jessica Johnson

    Even prostate tumors resistant to standard treatments responded to an experimental molecule in animal studies, raising the possibility of a different approach to advanced disease.

    Most cancer drugs work by blocking proteins or signaling pathways that help tumors grow. Researchers at the University of Michigan Health Rogel Cancer Center are testing a different approach. Instead of blocking two cancer-driving proteins separately, they have developed a molecule that locks them together, disrupting their activity and showing promising results against prostate cancer.

    The approach targets the androgen receptor (AR) and a helper protein called p300, which work together to activate genes that fuel prostate cancer growth.

    “Our molecule acts like a molecular brace, connecting these two cancer-driving proteins in an abnormal configuration that traps them in an inactive state,” said senior study author Arul M. Chinnaiyan, MD, PhD, director of the Michigan Center for Translational Pathology and S.P. Hicks Professor of Pathology at Michigan Medicine.

    “This shuts down two oncogenic signaling pathways simultaneously, enabling highly effective killing of tumor cells while sparing normal cells. Our preclinical findings suggest that this approach could offer a more effective treatment strategy for prostate cancer,” Chinnaiyan said.

    Gluing cancer-driving proteins together

    The researchers call the approach DALTAC, short for domain-alteration chimeras. It builds on a growing field known as chemically induced proximity, which uses small molecules to bring proteins together and change how they function. Related approaches include PROTACs, which trigger the breakdown of specific proteins, and transcriptional/epigenetic chemically induced proximity (TCIP), which alters gene regulation.

    “Our molecules consist of two inhibitors joined by a carefully designed short linker. By gluing two cancer-driving proteins together, they alter the proteins’ natural interactions,” said senior study author Shaomeng Wang, PhD, Warner-Lambert/Parke-Davis Professor in Medicine, professor of internal medicine, pharmacology and medicinal chemistry, and director of the Michigan Center for Therapeutic Innovation.

    Lasting responses in treatment-resistant tumors

    The team tested DALTAC molecules in prostate cancer cell lines, mouse models, and three-dimensional organoids derived from human cells. The molecules were more effective at killing tumor cells than combining separate AR and p300 inhibitors, with less toxicity to normal cells. In animal studies, they produced lasting responses and worked against tumors resistant to standard treatments.

    “Our optimized molecule is approximately 1,000 times more potent in tumor cells than the combination of inhibitors targeting these proteins separately, while sparing normal cells that lack these interactions. We also optimized the molecules for oral bioavailability, a key step toward developing a pill for patients,” Wang said.

    The findings, published in Nature, resulted from a collaboration between Chinnaiyan’s laboratory, which specializes in prostate cancer biology, and Wang’s laboratory, which focuses on medicinal chemistry and drug discovery.

    “These are remarkable preclinical results,” Chinnaiyan said. “The durable responses suggest an opportunity to develop a more effective treatment for advanced prostate cancer, including castration-resistant prostate cancer, if these findings translate to patients.”

    The research remains at the preclinical stage, and the approach has not yet been tested in humans.

    “Our teams are working closely to identify a drug candidate suitable for testing in human clinical trials,” Wang said.

    The researchers also believe that changing how proteins interact could offer a broader strategy for developing treatments against other cancers and protein targets beyond AR and p300.

    Reference: “Domain-alteration chimeras rewire oncogenic complexes in prostate cancer” by Jie Luo, Jianzhang Yang, Jean Ching-Yi Tien, Mi Wang, Sumit Das, Xiaoju Wang, Eleanor Young, Jelena Tošović, Rahul Mannan, Weiguo Xiang, Xia Jiang, Jocelyn Cai, Yihan Liu, Kenneth Gu, Somnath Mahapatra, Shiting Li, Yitong Yin, Sanjana Eyunni, Abigail J. Todd, Shicheng Jin, Xuhong Cao, Fengyun Su, Stephanie J. Miner, Ranga Sudharshan, Arvind Rao, Abhijit Parolia, Yuanyuan Qiao, Shaomeng Wang and Arul M. Chinnaiyan, 11 November 2026, Nature.
    DOI: 10.1038/s41586-026-11262-4

    This work was supported by the Rogel Cancer Center Proteomics Resource Facility Shared Resource.

    Disclosure: Wang and Chinnaiyan are cofounders of and hold equity in Medsyn Biopharma. The University of Michigan has filed patents related to the AR-p300 DALTACs, which have been licensed to Medsyn. U-M has received a research contract from Medsyn, for which Wang serves as the principal investigator.

    Never miss a breakthrough: Join the SciTechDaily newsletter.
    Follow us on Google and Google News.

    Cancer Molecular Biology Oncology Prostate Cancer University of Michigan
    Share. Facebook Twitter Pinterest LinkedIn Email Reddit

    Related Articles

    Scientists Discover a Hidden Weakness in Prostate Cancer That Could Transform Treatment

    Scientists Uncover New Weak Spot in Prostate Cancer Cells, a Game-Changer for Treatment

    Scientists Discover Key to Stopping Aggressive Prostate Cancer Subtype

    Avoid Unnecessary Biopsies: New Urine-Based Test Detects High-Grade Prostate Cancer

    Not So Safe: Common Cancer Medications Increase the Risk of Serious Medical Issues

    Hormone Therapy Treatments May Increase Survival Rate in Prostate Cancer Patients

    Novel Approach To Target Enhancer-Addicted Cancers – Potential Treatment Approach for Over 90% of Prostate Cancers

    New RNA Strategy Against Treatment-Resistant Prostate Cancer Identified

    Researchers Find a New Target to Treat a Wide Spectrum of Cancers

    Leave A Reply Cancel Reply

    • Facebook
    • Twitter
    • Pinterest
    • YouTube

    Don't Miss a Discovery

    Subscribe for the Latest in Science & Tech!

    Trending News

    Scientists Uncover a Bizarre Quantum Effect Where Time Could Flow at Different Speeds Simultaneously

    James Webb Telescope Reveals a Giant Planet That Was Hiding in Plain Sight

    Scientists Just Challenged a 50-Year-Old Theory About How Evolution Works

    Researchers Turn Moon Dust Into LEGO-Like Bricks That Could Build Future Lunar Bases

    Powerful New Weight-Loss Drug Could Change How Millions Treat Painful Knee Arthritis

    A 3-Million-Year-Old Fossil Is Turning the Story of Human Evolution Upside Down

    A Simple Pill Could Cure a Common Cause of High Blood Pressure

    A 6-Million-Year-Old Whale Had a Face So Strange Scientists Thought It Was Crushed

    Follow SciTechDaily
    • Facebook
    • Twitter
    • YouTube
    • Pinterest
    • Newsletter
    • RSS
    SciTech News
    • Biology News
    • Chemistry News
    • Earth News
    • Health News
    • Physics News
    • Science News
    • Space News
    • Technology News
    Recent Posts
    • Scientists Discover a Powerful New Way To Kill Prostate Cancer Cells
    • FDA Approves Breakthrough Treatment That Helps Children With Type 1 Diabetes Keep Producing Insulin
    • Not All Physical Activity Protects Your Brain, Scientists Warn
    • Arctic Bacteria May Be Using Sunlight and CO2 in a Way Scientists Never Expected
    • Earth’s Ancient Oceans May Have Fooled Scientists About the Rise of Oxygen
    Copyright © 1998 - 2026 SciTechDaily. All Rights Reserved.
    • Science News
    • About
    • Contact
    • Editorial Board
    • Privacy Policy
    • Terms of Use

    Type above and press Enter to search. Press Esc to cancel.